- Open Access
Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
© The Author(s) 2018
- Received: 19 February 2018
- Accepted: 19 February 2018
- Published: 9 March 2018
The original article was published in Cardiovascular Diabetology 2017 16:65
Following publication of the original article  the authors reported that the first affiliation (“Medical Center of the Graduate School, Nanchang University, China”) had been added in error, and that the correct author information is as given in this erratum.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.